HCW Biologics .
Developing transformative fusion immunotherapeutics for autoimmune diseases, cancer, and senescence-associated dysplasia.
Technology stack
detected 2026-06-09Reddit sentiment about HCW Biologics is mixed, with some positive signals from insider purchases and regaining rights to reagents, but also concerns regarding Nasdaq compliance and potential dilution.
“This filing concerns the resale of up to 5.7M shares of common stock by selling stockholders. The company is a clinical-stage biopharmaceutical firm developing fusion immunotherapeutics.”
View on Reddit“HCW Biologics registered shares for resale from a $4.0 million private placement, which included $600,000 from insiders, providing crucial capital amidst financial distress and Nasdaq compliance issues, though it comes with significant pote…”
View on Reddit“HCW Biologics Inc. received an extension from Nasdaq to regain compliance with the minimum $1 bid price rule, requiring demonstration by July 29, 2026, subject to conditions including a potential one-year Panel Monitor.”
View on Reddit“HCW Biologics Insider Purchases: HCW Biologics CEO Hing C. Wong acquires 113,879 common shares worth $160,499 HCW Biologics director Scott T. Garrett reports purchase of 177,936 shares for $249,501.12 HCW Biologics CFO Rebecca Byam acquires…”
View on Reddit“HCW Biologics CEO Hing C. Wong purchased $160,000 of company stock in a private placement, signaling strong conviction despite recent financial challenges and a pending dilutive offering.”
View on Reddit“HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen.”
View on RedditComments sourced from public Reddit discussions. Quotes are excerpts; click through to read the full thread.
What does HCW Biologics . do?
HCW Biologics is a biotechnology company focused on developing novel fusion protein therapeutics. Their platform aims to create revolutionary treatments for a range of challenging diseases, including autoimmune disorders, cancer, and conditions associated with aging like senescence-associated dysplasia.
How much funding has HCW Biologics . raised?
HCW Biologics . has raised a total of $25M in funding. The most recent round on record is Series A.
Where is HCW Biologics . headquartered?
HCW Biologics . is headquartered in Miramar, United States.
When was HCW Biologics . founded?
HCW Biologics . was founded in 2017.
What industry does HCW Biologics . operate in?
HCW Biologics . operates in Biotech, Drug Discovery, Immunotherapy, Autoimmune Diseases, Cancer, Longevity.